Hedge fund sounds alarm

SEOUL: For those investors lucky enough to have invested in South Korea’s health care sector, now may be the time to reassess the risks.

James Lim, a senior analyst at the US$3bil California-based hedge fund Dalton Investments LLC, is warning that retail investors could pull out of the nation’s equity market on unforeseen events such as an earlier-than-expected curb in the Covid-19 pandemic or a lifting of a short-sell ban. Drug-related shares are especially vulnerable because hopes for a virus cure have made them expensive, according to Lim.